Horizon Pharma, Plc. (NASDAQ:HZNP)

CAPS Rating: 2 out of 5

Results 1 - 8 of 8

Recs

0
Member Avatar stocky5 (39.41) Submitted: 7/1/2015 9:59:37 AM : Outperform Start Price: $35.26 HZNP Score: -10.03

Orphan drug segment is undervalued. Forward PEG is a reasonable 1.0. Analysts are on consensus raising both price targets and earnings estimates.

Recs

0
Member Avatar NHWeston102 (< 20) Submitted: 6/7/2015 7:30:23 PM : Outperform Start Price: $33.15 HZNP Score: -4.07

All the strengths of Activis pharma but at a dramatixally lower price. Buyout bait, too!!

Recs

0
Member Avatar manirg (96.06) Submitted: 3/19/2014 3:14:21 PM : Outperform Start Price: $15.82 HZNP Score: +80.26

With the addition of Videra & moving to Ireland, it is
inexpensive relative to other specialty pharma

Recs

0
Member Avatar HIGHG33K (91.03) Submitted: 2/4/2014 12:21:59 AM : Outperform Start Price: $10.10 HZNP Score: +177.43

Great value play

Recs

1
Member Avatar Rilac (98.26) Submitted: 9/4/2013 10:33:48 PM : Underperform Start Price: $2.55 HZNP Score: -1,021.89

doesn't look like Horizon Pharma Inc. is going to book any profits anytime soon.

Recs

0
Member Avatar rachelknopfler (< 20) Submitted: 7/30/2012 3:28:13 AM : Outperform Start Price: $6.09 HZNP Score: +337.64

THEY ARE CREATING NEW HEALTH TECHNOLOGIES TO MAKE HEALTHCARE AND HEALTH SENSORS MORE ACCESSIBLE TO THE MASSES.

Recs

0
Member Avatar madman27 (< 20) Submitted: 7/6/2012 8:26:21 PM : Outperform Start Price: $8.00 HZNP Score: +220.74

1)   Insiders are in over $9.
2)   Their drug is marketed overseas.
3)    # of shares outstanding is relatively small.
4)   recently went public.
5) PDUFA

Recs

0
Member Avatar SamsaricSufferer (49.12) Submitted: 7/4/2012 7:42:42 PM : Outperform Start Price: $8.03 HZNP Score: +220.96

PDUFA coming up

Results 1 - 8 of 8

Featured Broker Partners


Advertisement